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1. Gastric cancer as a public health problem 
 
Cancer is a leading cause of death in the world that has accounted for 7.6 million 
deaths (around 13% of all deaths) in 2008 [1] and the GLOBOCAN projections suggest that 
oncological diseases are likely to remain a major cause of mortality over the next couple of 
decades [2]. This increase will be determined for the most part by growth and aging of 
populations and will be largest in low- and medium-resource countries [3]. 
Gastric cancer is the fourth most common malignancy in the world, and it is estimated 
that approximately one million new cases of gastric cancer have occurred in 2008 [1]. 
The global burden of the gastric cancer can be measure by the economic value of 
disability-adjusted life years (DALY) [4]. In the year of 2008, in the world, gastric cancer is the 
second cancer accounting for the highest number of DALYs [5-6], with the mortality 
component contributing more for the burden of disease than the disability.  
 
1.1. Gastric cancer incidence 
 
Behind lung, breast and colorectal cancer, gastric cancer represents 9.7% of all 
cancers (excluding skin non-melanoma) in men and 5.8% in women (Table 1) [2]. 
Additionally, 72.2% of cases occur in developing countries (Table 1) and half the world total 
occurs in Eastern Asia [1]. Gastric cancer age-standardized incidence rates are about twice 
as high in men than in women [1, 7].  
 
Table 1. Gastric cancer incidence for men and women in 2008 
* World standard population 
Source: GLOBOCAN 2008 [1] 
 
In Europe, 145,889 new cases occurred in 2008, 86,865 in men and 59,024 in 
women, corresponding to an age-standardized incidence rate (European standard 
population) of 14.5/100,000 men and 7.0/100,000 women, respectively [1]. The highest age-
  Region 
 World More developed 
Countries 
Less developed 
countries 
 Men Women Men Women Men Women 
Number of cases  640031 348571 173014 101681 467017 246890 
Percentage of all cancers (excluding 
skin nonmelanoma)  
9.7 5.8 5.8 3.9 12.8 7.1 
Crude incidence rate (/100 000) 18.8 10.4 29.0 16.1 16.6 9.1 
Age-standardized * incidence rate 
(/100 000) 
19.8 9.1 16.7 7.3 21.1 10.0 
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standardized incidence rates are observed in countries like Japan (46.8/100,000 men) or 
Korea (62.2/100,000 men) [1]. In Africa, the age-standardized incidence rates are the lowest 
(4.7/100,000 men) [1].  
Despite these differences between the countries, in the last 50 years there have been 
widespread reductions in the gastric cancer incidence [8-9], mainly non-cardia gastric cancer 
[10-11]. Several studies showed an increasing [12-17] or unchanging incidence [18-21] of 
gastric cardia cancers. Cancers of the antrum and pylorus (non-cardia gastric cancer) tend to 
be most frequent in high-risk regions such as China, Japan, Eastern Europe and 
Central/South America [21-23], while gastric cardia cancers are more common where the 
overall gastric cancer incidence is lower [24]. 
The classification of the anatomical cardia region has changed over the years and 
cardia cancer was coded separately from other gastric cancers only after the 8th revision of 
the International Classification of Diseases (ICD-8) [25]. Difficulties in distinguishing between 
gastric cardia cancers and cancers of the lower third of the oesophagus are usual in the 
studies. In a report from the Swedish Cancer Register 15% of cardia cancer cases were 
classified as non-cardia gastric cancer and the observed increase in the incidence of cardia 
adenocarcinoma in the Swedish Cancer Register might be explained by disparities in tumour 
classification over time [25].  
The Laurén classification [26] categorizes the gastric tumours in two major types: 
intestinal or diffuse. Some carcinomas may not fit into one type or another, and thus fall into 
'mixed' or 'unclassified' categories [27]. The decline in incidence rates has been more 
pronounced in the intestinal type [28-29]. 
The reasons for the generalized decline in gastric cancer rates are complex and not 
completely know. A more varied and affluent diet and better food conservation, like a 
decreased reliance on salted and preserved foods; smoking decline in some parts of the 
developed world [9] and the decline in the frequency of Helicobacter pylori infection are 
potential explanations for the downward trends in gastric cancer incidence [7, 9, 30-32].  
 
1.2. Gastric cancer mortality 
 
Worldwide, gastric cancer is the second leading cause of cancer death [33] in both 
sexes with 737419 deaths in 2008 [1] and a corresponding age-standardized rate (world 
standard population) of 10.3 deaths/100,000 inhabitants (Table 2). About fifteen percent of 
the gastric cancer deaths occur in the more developed countries (Table 2). 
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Table 2. Gastric cancer mortality for men and women in 2008 
* World standard population 
Source: GLOBOCAN 2008 [1] 
 
The highest mortality rate estimates (age-standardized – world standard population) 
are observed for Eastern Asia, in countries like Mongolia (36.9/100,000 men; 17.6/100,000 
women) or China (30.1/100,000 men; 14.6/100,000 women), and the lowest in Northern 
America (2.8/100,000 men; 1.5/100,000 women), in the United States of America 
(2.7/100,000 men; 1.4/100,000 women) [1]. 
The gastric cancer mortality rate has fallen throughout Europe during the past 
decades [34-35], primarily due to the decrease of gastric cancer incidence rates, mostly as 
an effect of the extraordinary improvement of living conditions in European societies [36-38]. 
The reduction of 80,000 cancer deaths that was observed in the European Union from 1988 
to 1997 was largely attributed to the decline in gastric cancer rates, as in the same period the 
number of gastric cancer deaths decreased in 24,000 [39]. 
In addition to the impact of the mortality rates in the global burden of gastric cancer 
and taking into account the combination of the highest DALYs with the economic value of 
DALYs, the contribution of gastric cancer to economic value of DALYs varies from the 2th 
highest for lower middle income countries to the 4th highest in high income and upper middle 
income countries. In low income countries, gastric cancer is the 10th [5] (Table 3). 
 
 
 
 
 
 
 
 
  Region 
 World More developed 
countries 
Less developed 
countries 
 Men Women Men Women Men Women 
Number of cases  463930 273489 110245 70703 353685 202786 
Percentage of all cancers (excluding 
skin nonmelanoma)  
11 8.2 7.2 5.8 13.1 9.6 
Crude mortality rate (/100,000) 13.6 8.2 18.5 11.2 12.6 7.5 
Age-standardized * mortality rate 
(/100,000) 
14.2 6.9 10.3 4.7 16.0 8.1 
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Table 3. Estimated number of DALYs and the economic value of DALYs in the top five 
types of cancer country-income group in 2008 (current US $ billion) [5] 
 
 Cancer Type DALY 
(„000) 
Economic value (US $ bl.) 
 
 
High-income 
Trachea/bronchus/lung cancers 3754.7 151.8 
Colon/rectum cancer 2117.9 85.0 
Breast cancer 1828.9 73.9 
Stomach cancer 1033.6 41.8 
Lymphomas/multiple myeloma 900.3 36.4 
 
Upper-midlle 
income 
Trachea/bronchus/lung cancers  1433.7  12.8 
Colon/rectum cancer  854.8  7.6 
Breast cancer  846.1  7.5 
Stomach cancer  806.3  7.2 
Leukaemia  507.2  4.5  
 
Lower-midlle 
income 
Trachea/bronchus/lung cancers  5902.0 12.6 
Stomach cancer 4792.1 10.2 
Liver cancer  4589.2 9.8 
Esophagus cancer  2961.3 6.3 
Breast cancer 2448.4 5.2 
 
 
Low-income 
Mouth and oropharynx cancers  2252.4  
 
1.3 
Cervix uteri cancer  2191.0  
 
1.3 
Breast cancer 1899.3  
 
1.1 
Lymphomas/multiple myeloma 1844.3  1.1 
Trachea/bronchus/lung cancers 1720.7  1.0 
       Source: Jonh et al [5] 
 
1.3. Gastric cancer in Portugal 
 
In Portugal, gastric cancer is the third most common malignant tumour (Table 4) in 
both sexes with 2889 new cases in 2008, corresponding to age-standardized incidence rates 
of 19.2/100,000 men and 9.2/100,000 women [1]. 
In 2001, the incidence rates ranged from 32.1/100,000 in north region, 14.9/100,000 
in the center (age-standardized, European reference population) [40]. Considering separately 
men and women, the incidence rates for men are higher in the north of Portugal 
(45.0/100,000 men), followed by the south (25.0/100,000 men) and the center region 
(21.8/100,000 men) (age-standardized, European reference population) [40]. In women the 
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rates are 22.0/100,000 women in the north region, 11.9/100,000 women in the south and 
9.3/100,000 in the center (age-standardized, European reference population) [40]. 
 
Table 4. Proportion of cases of the most frequent cancers in Portugal 
 
 Both 
sexes 
  Men   Women 
 Incidence   Incidence   Incidence 
Colorectum 16.1%  Prostate 21.4%  Breast 27.7% 
Lung 7.6%  Colorectum 16.4%  Colorectum 15.6% 
Stomach 6.7%  Lung 10.9%  Stomach 5.7% 
Bladder 4.5%  Stomach 7.4%  Cervix uteri 4.9% 
Non-Hodgkin 
lymphoma 
3.4%  Bladder 6.2%  Corpus 
uteri 
4.4% 
Source: GLOBOCAN 2008 [1] 
 
According to RORENO (North Region Cancer Registry), in the north of Portugal, 
between 1997 and 2006 the incidence rate of gastric cancer decline in both sexes and was 
twice higher in men than in women [41]. In ROR Centro (Center Region Cancer Registry), in 
the same period, the incidence rate varied between years, but the smallest incidence rate 
was in 1998 and the highest was 2004 with differences between sexes (women with a lower 
incidence of gastric cancer) [42-51]. 
The last date available for the three registries combined in Portugal is from 2005 and 
the incidence rate for gastric cancer is 27.5/100,000 in men and 13.8/100,000 in women 
(age-standardized, European reference population) [52]. 
Population-based survival data in Portugal is available only from RORENO [53] and 
ROR-Sul (South Region Cancer Registry) [54]. 
In RORENO [53], the 5-year relative survival for cases diagnosed between 2000-
2001 was 32% for men and 37% for women. Regional differences were also observed, with 
the highest 5-year relative survival in Braga (42%) and the lowest in Viana do Castelo (22%). 
Considering both sexes, the ages group 55-64, 65-74 and ≥75 years present the lowest 
survival compare with the younger patients (15-44 years) [53]. In the south [54], the 5-year 
relative survival for cases diagnosed in the same period was 29% in men and 32% in 
women, and was higher in the region of Lisboa and Vale do Tejo. 
Five-year relative survival for gastric cancer in the region of RORENO, adjusted for 
age (population – International Cancer Survival Standards) was 32.6%, and 28.4% in ROR-
Sul (Figure 1) [53] 
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Figure 1. Five-year relative survival of gastric cancer patients diagnosed in 2000/2001 
in 16 European countries and two population based cancer registries from Portugal 
(RORENO and ROR-Sul) 
 
 
Source: RORENO [53] 
 
In Portugal, gastric cancer was responsible for 2423 deaths in 2008, corresponding to 
an age-standardized mortality rate of 10.5/100,000 inhabitants [1]. Gastric cancer is the third 
most common cause of oncological death in both sexes (Table 5). Separately, in men is the 
four most common cancer with 10.2% cases and in women the third most common with 9.6% 
(Table 5) and a age-standardized mortality rates in men of 15.0/100,000 and women 
6.8/100,000 [1]. 
 
Table 5. Proportion of oncological deaths due to the most frequent cancers in Portugal 
 
 Both sexes   Men   Women 
 Mortality   Mortality   Mortality 
Colorectum 15.2%  Lung 18.2%  Colorectum 16.4% 
Lung 13.7%  Colorectum 14.4%  Breast 15.9% 
Stomach 10.0%  Prostate 13.8%  Stomach 9.6% 
Pancreas 4.4%  Stomach 10.2%  Lung 6.8% 
Leukaemia 3.2%  Pancreas 3.9%  Pancreas 5.0% 
   Source: GLOBOCAN 2008 [1] 
 
Gastric cancer mortality in Portugal varies between regions, being higher in the north 
(19.8/100,000 inhabitants) and lower in the south (11.3/100,000 inhabitants) (Figure 2) [55]. 
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Figure 2. Age-standardized (European reference population) gastric cancer mortality 
rates (/100,000), by health region in 2006  
 
 
Source: Risco de Morrer em Portugal 2006 [55] 
 
Like in other European countries, the mortality rates in Portugal have been declining 
in the last decades [34].  
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2. Survival of gastric cancer patients 
 
Gastric cancer survival tends to be poorer in developing countries, most likely 
because of a delayed stage at diagnosis and a limited access to timely and standard 
treatment [7]. With few exceptions, survival tended to be higher amongst female than 
amongst male gastric cancer patients [56-57].  
In Europe, the 5-year mean relative survival increased from 15.0%, between 1978-
1980, to 21.0% in 1987-1989 [58]. Between 2000 and 2002 the 5-year mean relative survival 
estimate was 24.9%, similar to the observed in the USA (25.0%) [59] and furthermore in 
USA, the survival rates varies by race (between 2001-2007 5-year relative survival was 
26.1% for white race and 27.2% for black race) [60].  
Figure 3 depicts the variation in 5-year relative survival for gastric cancer in European 
countries between 1983 to 2002, with an increase being observed in most countries [61]. 
 
Figure 3. Trends in 5-year relative survival for adults (aged 15-99 years) diagnosed 
with gastric cancer in Europe between 1983 and 2002 
 
 
Standart population: (1983-1999) – age-distribution of cases of the overall European; (2000/02) – 
European standard cancer populations. 
Source: Eurocare database (1983-1999) [62] and Verdechia et al (2000/02) [59].  
 
The variation in gastric cancer survival across settings and with time is largely related 
with the relative weight of cancers with different characteristics regarding subsite, histological 
type and stage [63]. The countries with higher incidence rates of gastric cancer, in general 
have better survival rates than countries with lower incidence [63]. This is mainly due to 
differences in the proportion of cases with better or worse survival. There is an excellent 
15 
 
probability of long-term survival in patients treated in an early stage, while in patients with 
serosal involvement and lymph node metastasis the prognosis is extremely poor [64-68]. 
Efforts to increase the proportion of stage I cancers presenting for surgery can be shown to 
improve prognosis, by diagnosing the cancers when still surgically curable [67]. 
Regarding the Laurén classification of tumour, the histological type is an important 
independent determinant of survival, with the risk of dying being higher in the diffuse type 
cancers than in those of the intestinal type [69-70].  
Some authors [71-72] consider that age has prognostic value because young patients 
with gastric cancer have a poorer prognosis than older patients. Perhaps they present with 
more advanced disease because the index of suspicion for malignant disease is low and so 
the symptoms are allowed to progress for a longer period before investigation is considered, 
or there may be a greater biological activity of the tumour, which is more likely to be of the 
Laurén diffuse type.  
In the USA, between 1995-2000, the 5-year relative survival for distant stage and 
unstaged category was worse than for the localized and regional stage [6]. In Japan, as a 
result of population screening and probably a greater knowledge of early symptoms and a 
low threshold for diagnostic evaluation, 50% of gastric cancers are diagnosed at a localized 
stage, and the overall 5-year survival has increased from 20% in 1962 to 40% in 1992 [73]. 
Gastric cardia tumours have a much poorer prognosis compared to those in the 
pyloric antrum, with lower 5-year survival and higher operative mortality [74].  
Gastric cancer survival differences may be explained also by differences in the 
socioeconomic status of the patients [64, 75-78]. Patients with a higher income occupation 
and/or a higher educational level showed a better life expectancy. This may be associated 
with environmental exposures that may influence gastric cancer incidence [8] as well as 
prognosis [8]. The relation between behaviours before the diagnosis and the survival of 
gastric cancer patients remains poorly understood, and may contribute to a more 
comprehensive characterization of the burden associated with these exposures.  
It is reasonable to argue that diet could affect the progression of diet-related 
neoplasms and the probability of disease recurrence but only few studies address this topic. 
Frequent intake of fruits and vegetables appears to have a protective effect on survival [79-
80]. Huang et al. refer, in contrast, that other dietary items like salted fished, pickled food or 
red meat failed to show relationship with survival [79] and Palli et al. explain that a diet rich in 
animal protein may raise disease development in patients who are affected with familial 
gastric neoplasm [80]. 
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3. Objectives 
 
There is a large variation in gastric cancer survival across regions. The geographical 
and temporal differences in gastric cancer survival may be explained by a heterogeneous 
distribution of the access to early diagnosis and treatment across populations, as well as 
differences in the socioeconomic status of the patients. The latter may also be associated 
with environmental exposures with potential impact both in the risk of gastric cancer and the 
patients‟ prognosis. 
This dissertation addresses the association between pre-diagnosis lifestyle exposures 
and the survival of gastric cancer patients. It includes two studies with the following specific 
objectives:  
 To review systematically the published studies assessing the association 
between pre-diagnosis lifestyle exposures and the survival of gastric cancer 
patients (Paper I). 
 To quantify the association between pre-diagnosis lifestyle exposures and 
survival of gastric cancer patients in a Portuguese setting (Paper II). 
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Pre-diagnosis lifestyle exposures and survival of gastric cancer patients: systematic 
review and meta-analysis. 
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ABSTRACT 
 
The relation between lifestyles and gastric cancer has been thoroughly investigated, 
but few studies addressed the impact of these exposures on prognosis. Therefore, we 
quantified the association between pre-diagnosis smoking, alcohol intake and other dietary 
exposures and the survival of gastric cancer patients, through systematic review and meta-
analysis. We searched Pubmed® and EMBASE® up to April 2011, and computed summary 
Hazard ratio (HR) estimates and respective 95% confidence intervals (95%CI) through 
random-effects meta-analysis (DerSimonian and Laird). Heterogeneity was quantified using 
the I2 statistic. Seven articles, providing data from 6856 cases evaluated in seven countries 
(Canada, Japan, Italy, USA, Korea, Iran and Sweden), were eligible for meta-analysis. The 
summary HR was 1.08 (95%CI: 0.90-1.30) for smoking (current vs. never smokers, 7 
studies; I2=56.2%) and 1.13 (95%CI: 1.00-1.28) for alcohol consumption (drinkers vs. non-
drinkers, 5 studies; I2=13.2%). Only two studies assessed the effect of other dietary factors. 
This study summarizes the best evidence available on the relation between pre-diagnosis 
lifestyles and survival of gastric cancer patients. Alcohol drinkers have lower survival, but 
results on the effect of smoking lack consistency and there is almost no information on the 
effects of dietary factors. 
 
Key Words: Stomach neoplasms; Survival; Smoking; Alcohol Drinking; Meta-analysis. 
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Introduction 
 
Gastric cancer is worldwide the fourth most common malignancy, after lung, breast 
and colorectal cancers, despite the geographical differences in its frequency [1] and the 
widespread decline in incidence and mortality over the last decades [2]. The number of new 
cases and deaths continues to increase worldwide because of population growth and aging 
in high-risk countries. 
In Europe, 5-year relative survival increased from 15.0% between 1978-1980 to 
21.0% in 1987-1989 [3]. Among cases diagnosed between 2000 and 2002 the 5-year relative 
survival estimate was 24.9%, with wide geographical differences (e.g., 16.6% in Scotland 
and 33.2% in Italy) [4]. Within-country variability in survival has also been observed in 
several settings (e.g., Italy [5], United Kingdom [6]). 
The geographical and temporal differences in gastric cancer survival may be 
explained by a heterogeneous distribution of the access to early diagnosis, and treatment 
across populations [7] as well as differences in the socioeconomic status of the patients [8]. 
The latter may also be associated with environmental exposures with potential impact both in 
the risk of gastric cancer [9-10] and the patients‟ prognosis [11]. 
The understanding of the relation between pre-diagnosis lifestyles and survival may 
contribute to a more accurate characterization of the burden associated with these 
exposures. Therefore, we conducted a systematic review and meta-analysis of the published 
original research. 
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Materials and methods 
 
We searched Pubmed® and EMBASE®, from inception to April 2011, with no 
language restrictions. Reports of cohort studies that evaluated lifestyle determinants of 
survival in gastric cancer patients were eligible for the systematic review whenever providing 
quantitative estimates of the association and respective precision estimates. Review articles 
and conference proceedings were not included in the present review. The search 
expressions and the systematic review flow-chart are presented in Annex 1. 
The electronic database searches, the selection of articles and the extraction of data 
were conducted independently by two researchers (IF, AB), following a previously defined 
protocol. Discrepancies were resolved by consensus or involving another researcher (NL). 
Hazard ratios (HR), and respective precision estimates, for the association between 
lifestyle exposures and survival were extracted. When a study provided more than one 
estimate, we selected the one adjusted for the largest set of variables. When sex or gastric 
cancer subtype-specific HR estimates were available, the stratum-specific HRs were 
considered as if were obtained from different studies. 
From each study we further extracted data on the following variables: country; year of 
publication; characteristics of the participants; sample size; study design (methods of data 
collection, duration of follow-up); control of potential confounding. We contacted the authors 
by email to obtain information on these issues when not provided or not clearly presented in 
the original reports; some of the authors provided complementary information that was 
included in Annex 2. 
Random-effects meta-analyses, conducted using the DerSimonian and Laird method, 
were conducted to obtain summary measures for the association between pre-diagnosis 
lifestyles (highest vs. lowest exposures) and survival of gastric cancer patients.  
Publication bias was examined through visual inspection of the funnel plot. The Begg 
adjusted rank correlation test and the Egger´s regression asymmetry test were used for 
further assessment of bias through hypothesis testing. 
All analyses were conducted using STATA® version 11.2 (StataCorp, College Station, 
Texas, USA). 
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Results 
 
Seven studies [11-17] were eligible for the systematic review. All of them quantified 
the relation between smoking and survival of gastric cancer patients and the effects of 
alcohol consumption were addressed in five reports; dietary exposures were evaluated in two 
studies (Figure 1).  
The studies were published between 1985 and 2008; each of them referred to an 
investigation conducted in a different country: two in Europe (Italy and Sweden [11, 14]); 
three in Asia (Japan, Korea and Iran [13, 16-17]); two in North America (Canada and USA 
[12, 15]). 
In most studies the assessment of lifestyle exposures was accomplished by trained 
interviewers, and referred to the period before diagnosis. In two studies the interview was 
done with patients or families [15, 17]. Park et al. [16] evaluated participants with a self-
administrated questionnaire. Sundelof et al. [11] estimated the alcohol intake 20 years before 
the interview. In the report by Bako et al. [12] the period of exposure and the method used to 
obtain behavioural information from cancer patients was not specified. 
Only three studies [11, 13-14] provided HR estimates adjusted for the stage of the 
disease at diagnosis and one [15] provided the crude HR estimates (Annex 2). 
The summary HR for the relation between smoking (current vs. never smokers) and 
survival of gastric cancer patients was 1.08 (95%CI: 0.90-1.30), with a high heterogeneity 
across the HR estimates from each individual report (I2=56.2%). Alcohol consumption was 
significantly associated with a poorer survival (current vs. never drinkers – summary 
HR=1.13, 95%CI: 1.00-1.28), and results were homogeneous (I2=13.2%) (Figure 1). Only 
one study presented results for cardia and non-cardia cancers [15], with no differences 
according to cancer subsite, and Sundelof et al. [11] only evaluated cases of cancer of the 
cardia. 
In one of the reports [14] that assessed the effect of dietary exposure on survival, no 
significant associations were observed for any specific food or food group, except for α-
tocopherol (HR=0.75; 95%CI: 0.56-0.99). In the other study [13] the consumption of raw 
vegetables (HR 0.74; 95%CI: 0.56-0.99), bean curd (HR=0.65; 95%CI: 0.42-0.98) and 
chicken meat (HR=0.61; 95%CI: 0.39-0.94) were associated with a significantly higher 
survival. 
For alcohol consumption there was no evidence of publication bias by the visual 
inspection of the funnel plot (Figure 2), in accordance with the results from the Begg adjusted 
rank correlation test (P=0.851) and the Egger´s regression asymmetry test (P=0.840). For 
smoking the funnel plot suggests that small studies with a negative association may be 
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underrepresented (Begg adjusted rank correlation test, P=0.297; Egger´s regression 
asymmetry test, P=0.003). 
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Discussion 
 
This systematic review and meta-analysis summarizes the best evidence available on 
the relation between the lifestyles before diagnosis and survival of gastric cancer patients. 
Only 7 eligible studies, published over more that 20 years, were identified despite the 
comprehensiveness of the search strategy. We searched the two most important electronic 
databases – Pubmed® and EMBASE® – with no language restrictions, and using highly 
sensitive and unspecific search expressions, including the main terms referring to smoking, 
alcohol drinking and other dietary exposures. The “number-needed-to-read” was 277, which 
confirms the low specificity and high sensitivity of the searches. Furthermore, there was no 
evidence of publication bias for alcohol drinking, and the conclusions regarding the effects of 
smoking on gastric cancer survival are not likely to be influenced by a potential bias. 
The main findings of the present quantitative synthesis are naturally influenced by 
intrinsic limitations of the primary sources of information. In addition to the heterogeneous 
methods used in the different studies, all addressed the effects of pre-diagnosis exposures 
without taking into account possible behavioural changes occurring after the baseline 
evaluation. Previous investigations showed lifestyle modifications in cancer patients after 
diagnosis or treatment [18-19] and healthier lifestyles than the subjects at higher risk of 
developing a cancer [20-21]. However, despite the potential impact of post-diagnosis 
lifestyles in the survival of gastric cancer patients, the disease duration is relatively low and 
we may hypothesise that the cumulative exposures throughout life are more relevant as a 
potential determinant of survival. The conclusions of our meta-analyses apply only to pre-
diagnosis exposures, and further research is needed to address the impact of behavioural 
changes occurring after cancer diagnosis. 
Lifestyle predictors of survival have been studied for other cancers, namely breast 
[22-23], lung [24-25] and laryngeal carcinoma [26-28]. The results suggest that patients with 
a higher intake of fruits and vegetables before diagnosis have a better survival, and that 
smoking and drinking may be detrimental for prognosis, which is compatible with our 
observations for gastric cancer. 
The relatively small number of reports addressing this subject precludes more robust 
conclusions. However, our study provides a transparent and reproducible assessment of the 
published evidence on this topic. The potential effects of pre-diagnosis lifestyle exposures in 
the prognosis of gastric cancer patients seem relatively modest and well designed 
epidemiologic studies with large samples are needed for a more robust assessment of these 
determinants of survival. 
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Figure 1. Meta-analyses for the relation between smoking (current vs. never smokers) and 
alcohol drinking (current vs. never drinkers) and survival of gastric cancer patients 
 
 
 
Abbreviations: M – male; F – Female; GCC – Gastric Cardia Cancer; NCGC – Non-Cardia 
Gastric Cancer; 95%CI – 95% Confidence Interval. 
* The Hazard Ratio and respective 95%CI for the highest vs. lowest exposures were 
computed by the authors of the present review using the results for the lowest vs. highest 
exposure levels provided in the original report. 
NOTE: Weights are from random effects analysis
.
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Figure 2. Funnel plot of studies evaluating the association between smoking and alcohol 
drinking and survival of gastric cancer patients 
 
 
Abbreviations: Cl – Confidence limits 
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Annex 1. Systematic review flow-chart 
1290 potentially relevant references were
identified thought Pubmed® using the search
expression: (survival OR prognosis OR cox OR
Kaplan Meier) AND (gastric cancer OR cardia
cancer OR stomach cancer) AND (vitamin C OR
antioxidant OR lifestyle OR life style OR fruit OR
salt OR tobacco OR vegetables OR drinking OR
smoking OR alcohol OR coffee OR tea)
883 potentially relevant references were identified
thought Embase™ using the search expression: ("survival
analysis" OR prognosis OR "proportional hazards model"
OR "Kaplan Meier method") AND ("cardia carcinoma" OR
"stomach cancer") AND ("ascorbic acid" OR antioxidant
OR lifestyle OR fruit OR "salt intake" OR "sodium
chloride" OR tobacco OR vegetable OR drinking OR
smoking OR alcohol OR coffee OR tea)
2173 references
236 duplicate references 
1937 references
1927 references were excluded after evaluation of
the title/abstract because:
-271 were review articles/conference proceedings
-106 referred to animal studies
-1550 did not convey information about lifestyle
determinants in the survival of gastric cancer
patients
10 potentially eligible references
3 references were excluded after evaluation of
the full text because did not present information
regarding the association between gastric cancer
survival and lifestyle determinants
7 articles were included in the systematic review
Tobacco Alcohol Diet
7 articles 5 articles 2 articles 
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Annex 2. Summary of the studies evaluating the pre-diagnosis lifestyle exposures and survival of gastric cancer patients included in the systematic review 
1st author, yr 
Country 
(region) 
Participants’ characteristics Participants’ evaluation Follow-up Lifestyle factors 
HR (95% CI) 
Control of 
confounding 
Bako, 1985 
USA 
(Alberta) 
- Gastric cancer (n=467) 
- Recruitment: 1969-1973 
- The diagnosis of stomach cancer was 
confirmed in 97% of cases by 
pathology and in 3% by radiology or by 
clinical investigation 
- Men/women: 332/135 
- Age range (years): ≤30 to ≥80 
- Cancer site (cardia/pylorus/other 
specified parts/unspecified location):  
men – 16/30/149/137; 
women – 6/16/48/65 
- Stage 
(localized/regionalized/remote 
metastases/not stated): men – 
40/190/105/1; 
women – 18/70/45/2 
The instruments used for data collection or the 
timing of the evaluation are not described 
-Outcome: “mortality data for this study 
are based on death determined by the 
Alberta Cancer Registry and not by vital 
statistics”  
- The date of the diagnosis was used as 
the start of observation 
- Follow-up: up to December 31, 1981 
- All subjects had a minimum of 8-years of 
potential follow-up 
- Median survival (15 months) for both 
sexes 
- At the end of the study period, 33 males 
and 13 females patients had been 
withdraw alive from the study or had 
been lost to follow-up 
Smoking (smoker vs. never smoker) 
men – 0.98 (0.70-1.37) 
a 
women – 0.99(0.42-2.35) 
a 
Not available 
Huang, 2000 
Japan 
- Gastric cancer (n=877) 
- Recruitment: 1988-1994 
- Pathologically confirmed cases of 
gastric adenocarcinoma that survived 
through the immediate postoperative 
period 
- Men/women: 578/299 
- Age range (years): 40 to >79 
- Pathological stage (I/II/III/IV):  
men – 329/64/69/116; 
women – 66/32/47/54 
- Histological type b 
(PA/TA/PDA/SRCC/MA/ST): 
men – 13/289/184/51/14/25;  
women – 6/86/133/62/5/7 
- Questionnaire survey started in 1988 covering 
all first-visit outpatients before their 
examination and diagnosis in the ACC c. 
- Questionnaire topics: personal behaviour, 
habitual smoking and drinking, and beverage 
and food intake, as well as reproductive and 
general health status, before symptoms 
appeared 
- Outcome: gastric cancer as the primary 
cause of death, determined by the 
records of the ACC 
- The date of the diagnosis was used as 
the start of observation 
- Follow-up: up to December 31, 1998 
- At the end of follow-up 636 patients 
were still alive (72.2% males vs. 73.2% 
females) 
- All patients were traced completely 
Smoking (current vs. never) 
2.54 (1.22-5.29) 
Number of cigarettes 
(<30 vs. 0/day) 
1.49 (0.89-2.49) 
 
Habitual drinking (current vs. never) 
1.36 (0.91-2.02) 
Quantity of alcohol d
 
≥2.0 vs. 0 go/day 
1.08 (0.70-1.66) 
 
Fruit (>3 vs. ≤ 3 times/wk) 
0.98 (0.73-1.31) 
Raw vegetables (>3 times/wk vs. ≤ 3 
times/wk) 
0.74 (0.56-0.99) 
Age 
Pathological type 
Stage of cancer 
Gender (only 
fruit/ raw 
vegetables) 
Palli, 2000
 
Italy 
(Florence) 
 
- Gastric cancer (n=382) 
- Recruitment: 1985-1987 
- Histologically confirmed cases with 
staging information available 
- Men/women: 239/143 
- Questionnaire topics: smoking history, alcohol 
use and other dietary information (done by 
trained dietitians focused on the 12-month 
period 1 year prior to the onset of symptoms or 
prior to surgery)  
- Outcome: mortality data was based on 
all causes determined by the records of 
Municipal Population Offices and to the 
Regional Mortality Registry on December 
31, 1997 
Smoking (current vs. never) 
1.04 (0.75-1.45) 
 
Alcohol (3 rd vs. 1st third) 
1.41 (1.04-1.91) 
Age (continuous)  
Gender 
Social status  
Pathologic stage 
at diagnosis (T 
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- Age range (years): <50 to >64 
- Laurén classification 
(intestinal/diffuse/mixed): 234/89/57 
- Histopathologic grading (G1/G2/G3): 
38/80/264 
- Lymph node involvement (no/yes): 
73/309 
- T classification (T1/T2/T3/T4): 
34 /68/130/150 
- Diet was assessed by asking the usual 
frequency of consumption of 181 food items 
and beverages 
 
- The information on mortality at 10 years 
was available for all but three patients 
(0.8%) – these patients were censored 
- The date of the interview was used as 
the start of observation 
- The 65 patients who were still alive at 
the end of the study had a mean follow-
up of 134 months (range, 120–150 
months) 
 
Total calories (3 rd vs. 1st third) 
0.91 (0.68-1.20) 
Vitamin C (3 rd vs. 1st third) 
1.02 (0.77-1.36) 
Retinol (3 rd vs. 1st third) 
1.13 (0.86-1.49) 
Beta carotene (3 rd vs. 1st third) 
1.13(0.85-1.49) 
Vitamin E (3 rd vs. 1st third) 
0.75 (0.56-0.99) 
and N 
classification) 
Lymph node 
involvement 
 
Trivers, 2005 
USA 
(Washington 
state/ New 
Jersey/ 
Connecticut) 
- Gastric cardia cancer (GCC e) (n=261) 
and non cardia gastric cancer (NCGC f) 
(n=367) 
- Recruitment: 1993-1995  
- Men/women: 
GCC – 223/38; NCGC – 253/114 
- Age range (years): 31 to 79  
- Stage 
(localized/regional/distant/unknown): 
GCC – 34/120/70/37; NCGC – 
70/161/104/32 
- Tumor grade (WMD/PDU/ND) g: 
GCC – 97/137/27; NCGC – 101/214/52 
- Questionnaire topics: tobacco and alcohol 
history (done by trained interviewers focused in 
anytime prior to one year before the interview) 
- The mean length of time between cancer 
diagnosis and the interview was 3.7 months 
when the interview was conducted with the 
case subjects and 8.5 months when the 
interview was conducted with a proxy. 
- Outcome: mortality data was based on “ 
any cause” determined by the records of 
the National Death Index, with maximum 
follow-up of 90 months 
- The date of the diagnosis was used as 
the start of observation 
- Follow-up: up to July, 2000 in 
Washington state; September, 2000 in 
New Jersey and October, 2000 in 
Connecticut 
- Three patients were excluded from all 
analyses (2 patients lost to follow-up, 1 
patient owing to a discrepancy between 
the date of diagnosis and death). 
Alcohol drinking (ever h vs. never) 
GCC – 0.87 (0.64-1.18) 
NCGC – 1.09 (0.85-1.40) 
 
Cigarette smoking (ever i vs. never) 
GCC – 0.99 (0.71-1.38) 
NCGC – 1.02 (0.79-1.32) 
 
 
 
 
 
 
Only crude HRs 
were provided 
Park,2006 
Korea 
- Gastric cancer (n=3979) 
- Recruitment: 1996-2002 
- Patients who were diagnosed with 
multiple primary cancer were excluded 
(n=418) 
- Only men 
- Age range (years): ≥20 
- Information regarding tobacco history, alcohol 
use and dietary preferences was obtained with 
a self-administered questionnaire that could be 
applied before or after the diagnosis 
- Outcome: “mortality data by linkage to 
the National Statistical Office” between 
1996 and 2004 
- The date of the diagnosis was used as 
the start of observation 
- Follow-up: up to December, 2004 
Smoking (current vs. never) 
0.83 (0.72-0.95) 
 
Alcohol consumption 
≥124.2 vs. 0 
1.13 (0.96-1.32) 
Age 
Alcohol 
consumption 
Body mass index 
Fasting serum 
glucose level 
Cholesterol level  
Physical activity 
Food preference 
Blood pressure 
Heart disease 
Liver disease 
Cerebrovascular 
disease 
Samadi, 
2007 
Iran 
(Ardabil 
Province) 
- Gastric cancer (n=279) 
- Recruitment: 2000-2004 
- Biopsy-proven patients 
- Men/women: 217/62 
- Age range (years): >20 to <90 
 
- Face to face interview (patients or families) at 
the time of diagnosis at Aras Clinic 
 
- Outcome: “direct interview with patients 
or their families” and “evaluation of death 
certificates” (n=55) 
- The date of the diagnosis was used as 
the start of observation 
-Follow-up was from diagnosis until death 
Smoking (yes vs. no) 
1.81 (1.02-3.23) 
Sex  
Age  
Residence  
Surgery  
Chemotherapy  
Radiotherapy  
30 
 
 
 
or immigration Smoking  
Differentiation 
Education  
Sundelof, 
2008 
Sweden 
- Gastric cardia cancer (n=244) 
- Recruitment: 1994-1997 
- Cases born and still living in Sweden 
- Men/women: 208/36 
- Age range (years): <80 
 
- Questionnaire topics: history of tobacco use; 
alcohol intake 20 years before interview 
- Outcome: “through cross-linkage to the 
nationwide Swedish Death Register” 
- The date of the diagnosis was used as 
the start of observation 
- Follow-up: from the date of diagnosis 
until the date of death or end of study 
(December, 31 of 2004), whichever 
occurred first. 
Smoking (current smokers vs. never) 
1.4 (0.8-2.2) 
 
Alcohol intake (>70 g/week vs. never) 
1.1 (0.6-1.9) 
Tumour stage 
Sex 
Age 
Education Level 
Symptomatic 
reflux 
Body mass index 
Smoking 
Alcohol intake 
Physical activity 
Oesophagectomy 
 
Abbreviations: 
a
 The Hazard Ratio and respective 95%CI for the highest vs. lowest exposures were computed by the authors of the present review using the results for the lowest vs. highest exposure levels 
provided in the original study; 
b 
Histological type: 
 
PA – Papillary Adenocarcinoma; TA – Tubular adenocarcinoma; PDA – Poorly differentiated adenocarcinoma; SRCC – Signet-ring cell carcinoma; 
MA – Mucinous adenocarcinoma; ST – Special types; 
c
 ACC – Aichi Cancer Center; 
d 
1 go = 180 ml Japanese wine; 
e 
GCC – Gastric cardia cancer ; 
f 
NCGC – Non-cardia gastric cancer;
 g
 Tumor 
grade: WMD – Well/moderate differentiated; PDU – Poorly differentiated/undifferentiated; ND – Not determined; 
 h 
at least 1 alcoholic drink (12 oz. beer, 4 oz. glass of wine, 1 drink with hard liquor) 
per month, for 6 months; 
i
 at least 1 cigarette(s)/day for 6 months. 
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Abstract 
 
Dietary habits and smoking are recognized as important gastric cancer determinants. 
However, their impact on prognosis remains poorly understood. We aimed to quantify the 
association between lifestyles and the survival of gastric cancer patients in a large sample of 
gastric cancer cases with a long follow-up. The study included 568 patients recruited in the 
two major public hospitals in the north of Portugal (2001-2006). Participants were inquired 
about pre-diagnosis smoking and dietary habits regarding the year preceding the diagnosis. 
The latter were recorded using a validated semi-quantitative food frequency questionnaire 
and data were analysed by food group and dietary pattern. The vital status of all participants, 
up to 2011 (maximum follow-up: 10 years), was assessed through the North Region Cancer 
Registry. Survival curves were estimated by the Kaplan-Meier method. Cox proportional 
hazards regression models were used to estimate age-, sex-, education- and extent of 
disease-adjusted hazard ratios (HRs) and 95% confidence intervals (95%CI). Only a dietary 
pattern characterized by high consumptions of most food groups and low vegetable soup 
intake was significantly associated with a better prognosis among patients with the extent of 
disease classified as regional spread (HR=0.45; 95%CI, 0.22-0.93). No significant 
associations were observed for other variables (alcohol, smoking, consumption of fruits and 
vegetables, red and processed meat or foods with the highest contribution for sodium 
intake). This study shows that pre-diagnosis lifestyles have a small impact in the survival of 
gastric cancer patients. 
 
Key Words: Stomach neoplasms; Survival; Smoking; Alcohol Drinking; Diet. 
36 
 
Introduction 
 
Gastric cancer is the fourth most common malignancy in the world [1]. Although its 
frequency has been declining for decades it remains the second leading cause of cancer 
mortality [2] and ranks second among the cancers accounting for the highest number of 
disability-adjusted life years (DALYs) (9.6%) [3-4]. In Europe, the average 5-year relative 
survival rate of patients diagnosed between 2000 and 2002 was estimated in 24.9%, 
however varying widely across countries [5]. 
The prognosis of gastric cancer patients varies with the tumour‟s characteristics, 
namely location and histological type, and it is also likely to be related with the 
socioeconomic status of the patients [6].The latter, in addition to its relation with access to 
health care and stage at diagnosis [7], may also be associated with environmental exposures 
with potential impact both in the risk of gastric cancer and in the survival of cancer patients 
[8-9]. The understanding of the relation between pre-diagnosis lifestyles and survival may 
contribute to a more accurate characterization of the burden associated with these 
exposures. However, the effect of behavioural factors, such as alcohol drinking, tobacco 
smoking and dietary habits, on the survival of gastric cancer patients has seldom been 
addressed and available evidence showed inconsistent results [10]. 
Therefore, we aimed to quantify the association between pre-diagnosis lifestyles and 
the survival of gastric cancer patients, in a large sample followed prospectively for up to 10 
years, with special emphasis on the potential modification of the effects according to the time 
of survival. 
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Methods 
 
Setting and selection of participants 
As part of a case-control study previously described in detail [11-13] we evaluated 
incident cases of gastric cancer selected among those admitted to the surgery wards of the 
two major public hospitals for cancer patients in the north of Portugal (Hospital de S. João 
and Instituto Português de Oncologia Francisco Gentil, both in Porto), between June 2001 
and December 2006. 
Eligible patients were incident gastric cancer cases that had not been previously 
diagnosed with cancer (except skin non-melanoma), nor had been subjected to subtotal 
gastrectomy for benign conditions; they also had to be able to provide informed consent. To 
evaluate cognitive function, all individuals older than 64 years took a Mini-Mental State 
Examination [14] and we restricted the analysis to participants without serious cognitive 
impairment at baseline (score ≥18 points) [15]. 
 
Evaluation of environmental exposures 
The participants completed a comprehensive structured questionnaire providing 
information on demographic, social, behavioural and medical characteristics, applied by 
trained interviewers during in-hospital stay, shortly after admission, mostly before surgical 
treatment. Since illness duration is related with changes in food intake, the assessment of 
the dietary intake referred to the previous year or the year before onset of symptoms, as 
applicable. We excluded from the analyses the patients declaring to have changed dietary 
habits more than one year before the interview. 
Dietary exposures were quantified using a semi-quantitative food frequency 
questionnaire (FFQ) comprising 82 food/beverage items or categories, designed according to 
Willett [16] and adapted by inclusion of a variety of typical Portuguese food items. Foods with 
a similar nutrient composition were grouped together as a single item. The FFQ was 
validated with a 7-day food record and, regarding the fatty acid composition, with the 
composition of subcutaneous adipose tissue [17-18]. For each FFQ item, subjects were 
asked the average frequency of consumption (nine possible responses ranging from never to 
six or more times per day), the portion size usually consumed (based on a photograph 
manual with small, medium, and large portion sizes), and the number of months during which 
it had been consumed in the previous year. Also, for each item, this information was used to 
estimate the frequency of consumption of medium servings, corrected for seasonality by 
multiplying the reported consumption by the ratio between the number of months during 
which the food item was reported to be consumed and 12 months. For analysis, the 
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frequency of consumption of each food group was categorized using the tertiles of the overall 
distribution as cut-offs. 
The overall intake of fruits and vegetables, red and processed meat and foods with a 
high contribution to salt intake was established by adding up the amounts of single items or 
groups consumed per day, as follows: fruits and vegetables (apple or pear, orange or 
mandarin, banana, kiwi, strawberry, cherry, peach or plum, melon or watermelon, 
persimmon, fig or loquat or apricot, grapes, natural fruit juices, lettuce, watercress, tomato, 
cucumber, green and white cabbages, broccoli, cauliflower or Brussels sprout, spinach or 
spring greens or turnip greens, spinach, bean pod, carrot, turnip, green beans, green pepper, 
onion, beans and peas); red and processed meat (beef, pork, liver, tongue, ham, sausage, 
bacon, hamburger); food items with the highest contribution to sodium intake (namely grains, 
cereals, rice, pasta, potatoes, bread, meat, meat products, offal, vegetable soup, fish and 
cheese). The latter were defined according to the results of a previous nutrition survey 
conducted in same setting [19]. 
Dietary patterns were defined by principal components and cluster analyses, as 
previously described in detail [20]. Three dietary patterns were identified (Pattern I – high 
consumption of fruits and dairy products, and low consumption of alcoholic beverages; 
Pattern II – low consumption of fruit, salads, vegetables, dairy products, fish and meat; 
Pattern III – high consumptions of most food groups and low vegetable soup intake). Pattern 
II was shown previously to be associated with a higher risk of gastric cancer when compared 
with patterns I or III [20]. 
Smoking and alcohol consumption status were assessed. Individuals smoking 
regularly at least one cigarette per day were classified as current smokers and those who 
stopped smoking at least 6 months before the interview as former smokers [21]. Individuals 
drinking regularly at least one alcoholic drink per day were classified as current drinkers and 
those who stopped drinking at least 6 months before the interview as former drinkers. 
 
Clinical characteristics 
The anatomic site (cardia/non-cardia/not defined) and histological type of the tumours 
(intestinal/diffused/mixed) were classified according to the routine procedures of both 
institutions, based on gastrectomy specimens or endoscopic biopsy material. To guarantee a 
standard pathologic classification according to the Laurén criteria, a single experienced 
pathologist reviewed all pathology reports and slides were reassessed whenever necessary. 
For a more accurate classification of the tumour histological type [22-23] only those cases 
from whom a surgical specimen was available were considered for the analyses including 
information on the tumours‟ histological type (78% of the patients eligible for data analysis). 
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The information on the extent of disease, according to the European Network of 
Cancer Registries criteria [24], was obtained from the North Region Cancer Registry 
(RORENO). 
 
Follow-up 
The vital status of the participants was assessed by the RORENO. The event of 
interest was death by all causes. Patients were followed until the end of July, 2011, or date of 
death, whichever occurred first. No follow-up information could be obtained for 10 patients. 
The median duration of follow-up was 6.6 years for patients alive at the end of study and 1.2 
years for those reported dead, with a maximum follow-up of 10 years. 
 
Statistical analysis 
A total of 568 gastric cancer patients with follow-up information were available for 
data analysis. We used the Kaplan-Meier survival function to estimate the observed survival 
at 1, 3 and 5 years of follow-up, and Cox proportional hazard regression analysis to compute 
adjusted hazard ratios (HR) with the corresponding 95% confidence intervals (95%CI). 
Differences in survival estimates between groups were tested using the Log-rank test. 
All analyses were conducted using STATA®, version 11.2 (StataCorp, College 
Station, Texas, USA). 
 
Ethics 
The study was approved by the ethics committees of the involved hospitals and the 
participants provided written informed consent. 
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Results 
 
Characteristics of the participants 
Incident gastric cancer patients were mostly men (62.1%) and nearly one-quarter 
were aged 50 years or less (median age of 63 years). Approximately three-quarters of the 
participants had 4 or less schooling years. Most cancers were located in the non-cardia 
region (78.6%), and 55% of those from whom a surgical specimen was available were of the 
Laurén‟s intestinal histological type. No information was available to classify 16.9% of the 
cases according to the extent of disease, and one-quarter were advanced cancers (Table 1). 
At baseline, approximately one-fifth of the patients were smokers and one-quarter ex-
smokers, while 72.9% reported being current drinkers. The median daily consumption of 
fruits and vegetables, red and processed meat and foods accounting for high salt intake was 
3.4, 0.7 and 2.0 servings, respectively (Table 2). 
 
Observed survival 
Survival decreased significantly with age (P=0.001). Patients aged 24-50 years and 
51-60 years had a similar survival until the third year of follow-up, diverging only after that 
(Figure 1). Only 32.0% and 7.0% of the patients with an advanced cancer were alive at one 
and three years after diagnosis, respectively. The patients with unknown stage had a survival 
in-between the observed for the regional spread and advanced cancers until the 5 years of 
follow-up, and thereafter closer to the observed for cases with regional spread (Figure 2).  
Women presented a significantly lower survival than men (35.8% vs. 44.2% at 5 
years, P=0.016). Cardia cancers had worse survival than the non-cardia (29.0 vs. 46.3 at 5 
years), as well as those of the Laurén‟s diffuse type compared with the intestinal (36.2 vs. 
56.6 at 5 years) (Table 1). 
Regarding the relation with lifestyle characteristics, significant differences were 
observed only according to the smoking status (P=0.039), with never smokers having a 
poorer survival than current smokers (36.8 vs. 43.7 at 5 years) (Table 2). 
There were virtually no changes in the results when excluding the patients who died 
up to one week after the surgery that could be considered due to postoperative complications 
(data not shown). 
 
Multivariate analysis 
No independent meaningful or statistical significant associations were observed 
between the pre-diagnosis lifestyles and gastric cancer survival, overall or across strata 
defined by cancer subsite, histological type or stage, except for a significantly lower hazard 
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rate among regional spread patients with dietary pattern III (high consumptions of most food 
groups and low vegetable soup intake), compared with those with pattern I (high 
consumption of fruits and dairy products, and low consumption of alcoholic beverages) 
(HR=0.45, 95%CI; 0.22-0.93). A similar relation was observed among those with 
localised/local spread patients, though not statistically significant. 
The strongest associations with an increased hazard rate, though not statistically 
significant, were observed among the patients with localised/local spread cancer for smoking 
(current vs. never, HR=2.17, 95%CI, 0.51-9.23) and consumption of higher amounts of fruits 
and vegetables (3rd third vs. 1st third, HR=2.30, 95%CI, 0.78-6.74) and red and processed 
meat (3rd third vs. 1st third, HR=2.03, 95%CI, 0.66-6.24). 
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Discussion 
 
The present study shows no significant associations between pre-diagnosis lifestyles 
and gastric cancer survival, with the exception of a lower hazard rate among patients with 
less advanced disease reporting a dietary pattern that is also associated with a lower risk of 
gastric cancer. 
This is one of the few investigations [10] on the association between pre-diagnosis 
behaviours and gastric cancer survival. In addition to providing evidence on a topic that has 
seldom been addressed before, there are several distinctive methodological characteristics 
of the present investigation that contribute to the robustness and validity of the findings. It is 
based in a large case series of patients followed for a long period, which allows a stratified 
analysis according to the extent of disease, and consequently the estimation of the impact of 
these exposures specifically for subgroups of patients with short and long survival periods. 
This strategy of analysis has not been used in the previous studies, although we may 
hypothesise that lifestyles adopted for several years before diagnosis are unlikely to be 
responsible for the differences in mortality of gastric cancer patients shortly after the disease 
is diagnosed. This is supported by our results that showed significant associations only 
among the patients that survived for longer periods, although it contributes for two limitations 
of our study. On the one hand, the endpoint was all-cause mortality, because no information 
on the cause of death was available. Although the former may be a surrogate of gastric 
cancer mortality due to the low overall survival of gastric cancer patients, this is less likely 
among the subjects presenting with less advanced disease. Therefore, the factors that we 
identified as being associated with lower hazard rate are not necessarily decreasing the risk 
of death due to gastric cancer. On the other hand, previous investigations showed that 
cancer patients may adopt healthier lifestyles after diagnosis or treatment [25-27]. This could 
contribute for differences in survival according to lifestyle changes after gastric cancer 
diagnosis, but these were not assessed in our study, and their potential confounding effect 
could not be accounted. 
Only two previous reports addressed the effect of dietary exposures on the survival of 
gastric cancer patients [28-29], and our investigation provides new evidence on these 
potential determinants of prognosis. In addition to using valid methods to assess dietary 
intake prior to cancer diagnosis or symptoms, we analysed the potential effect of the 
exposure to food groups known to be associated with the risk of gastric cancer, as well as 
the effect of dietary patterns. The latter provides an additional tool to understand the impact 
of diet in cancer survival.  
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Our study also adds to previous research on this topic the subgroup analyses 
according to anatomic site and histological type. Although these clinical characteristics 
influence survival, no differences were observed according to pre-diagnosis exposures within 
each of these groups of patients. 
In conclusion, pre-diagnosis lifestyles have a small impact in the survival of gastric 
cancer patients. 
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 Table 1. Observed survival of gastric cancer patients at one-, three- and five-years 
according to socio-demographic and clinical characteristics  
      Observed survival (%)
b
 
  n (%)
b
  Deaths during  
follow-up (n) 
 1 year 3 years 5 years P value 
Sex 
     Women 
     Men 
  
215 (37.9) 
353 (62.1) 
  
142 
203 
  
65.6 
75.9 
 
43.3 
52.7 
 
35.8 
44.2 
0.016 
Age (years) 
     ≤50 
     51-60 
     61-70 
     71-80 
     ≥81 
  
131 (23.1) 
120 (21.1) 
156 (27.5) 
129 (22.7) 
32 (5.6) 
  
65 
66 
98 
92 
24 
  
79.4 
78.3 
66.0 
66.7 
68.8 
 
57.3 
56.7 
44.2 
39.5 
50.0 
 
51.9 
45.0 
38.5 
31.0 
34.4 
0.001 
Education (years) 
     0 
     1-3 
     4 
     5-9 
     ≥10 
  
65 (11.4) 
98 (17.3) 
282 (49.7) 
89 (15.7) 
34 (6.0) 
  
46 
67 
161 
49 
22 
  
60.0 
62.2 
76.2 
78.7 
70.6 
 
40.0 
40.8 
51.4 
59.6 
44.1 
 
33.9 
33.7 
44.3 
46.0 
35.3 
0.027 
Anatomic site
 
     Cardia 
     Non-cardia 
     Not-classified 
  
69 (12.2) 
447 (78.6) 
52 (9.2) 
  
51 
248 
46 
  
62.3 
79.0 
25.0 
 
37.7 
55.3 
11.5 
 
29.0 
46.3 
11.5 
<0.001 
Histological type 
a 
     Intestinal 
     Diffuse 
     Mixed 
  
244 (55.0) 
127 (28.6) 
73 (16.4) 
  
113 
82 
42 
  
86.5 
78.0 
78.1 
 
65.2 
47.2 
52.1 
 
56.6 
36.2 
43.8 
0.001 
Extent of disease
  
     Localised 
     Local spread 
     Regional spread 
     Advanced 
     Unknown 
  
112 (19.7) 
37 (6.5) 
181 (31.9) 
142 (25.0) 
96 (16.9) 
  
11 
11 
121 
137 
65 
  
96.4 
97.3 
86.2 
32.4 
66.6 
 
92.7 
81.1 
54.7 
7.0 
37.5 
 
91.1 
73.0 
36.4 
4.9 
32.3 
<0.001 
 
a 
This information is available from 444 patients that underwent surgical resection of the stomach; 
b
 
The sum of percentages may be different from 100% due to rounding. 
.
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Table 2. Observed survival of gastric cancer patients at one-, three- and five-years according to 
lifestyle characteristics 
      Observed survival (%)
a
 
  n (%)
a
  Deaths during 
follow-up (n) 
 1 
year 
3 
years 
5 
years 
P 
value 
Smoking status 
   Never smokers 
   Ex-smokers 
   Current smokers 
  
318 (56.0) 
138 (24.3) 
112 (19.7) 
  
209 
73 
63 
  
70.1 
76.1 
72.3 
 
45.9 
55.1 
50.9 
 
36.8 
48.6 
43.7 
0.039 
Alcohol status 
   Never drinkers 
   Ex- drinkers 
   Current drinkers 
  
72 (12.7) 
82 (14.4) 
414 (72.9) 
  
41 
51 
253 
  
70.8 
69.5 
72.7 
 
51.4 
45.1 
49.5 
 
44.4 
39.0 
40.8 
0.822 
Fruits and vegetables  
   1
st 
third 
   2
nd 
third
 
   3
rd 
third
 
  
189 (33.3) 
190 (33.4) 
189 (33.3) 
  
114 
120 
111 
  
71.4 
71.6 
73.0 
 
50.3 
46.8 
50.3 
 
41.8 
38.9 
42.3 
0.663 
Red/processed meat 
   1
st 
third 
   2
nd 
third
 
   3
rd 
third 
  
192 (33.8) 
188 (33.1) 
188 (33.1) 
  
120 
120 
105 
  
67.7 
72.9 
75.5 
 
46.9 
47.3 
53.2 
 
39.6 
38.3 
45.2 
0.235 
Sodium intake 
   1
st 
third 
   2
nd 
third
 
   3
rd 
third
 
  
190 (33.4) 
189 (33.3) 
189 (33.3) 
  
119 
119 
107 
  
71.1 
69.3 
75.7 
 
45.8 
43.9 
57.7 
 
40.0 
37.6 
45.5 
0.166 
Dietary patterns 
   Pattern I 
   Pattern II (high-risk)
 
   Pattern III 
  
229 (40.3) 
270 (47.5) 
69 (12.2) 
  
141 
168 
36 
  
70.3 
73.0 
73.9 
 
48.0 
48.2 
56.5 
 
39.7 
40.0 
49.3 
0.400 
 
a
 The sum of percentages may be different from 100% due to rounding. 
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Table 3. Adjusted Hazard Ratios and corresponding 95% Confidence Intervals for lifestyle characteristics using multivariate Cox regression model 
   Anatomic site
  
Histological type 
  
Extent of disease 
 
   Cardia
  
Non-cardia 
  
Intestinal Diffuse
  
Localised and  
local spread 
Regional spread Advanced 
 
 
HR 
a 
(95% CI)
 
HR 
b 
(95% CI)
 
HR 
b 
(95% CI)
 
 
HR 
b 
(95% CI)
 
HR 
b 
(95% CI)
 
 
HR 
c 
(95% CI) 
HR 
c 
(95% CI) 
HR 
c 
(95% CI) 
Smoking status 
  Never smokers 
  Ex-smokers 
  Current smokers 
  
1 
0.90 (0.66-1.23) 
1.00 (0.72-1.38) 
 
1 
0.76 (0.31-1.89) 
1.31 (0.62-2.77) 
 
1 
0.83 (0.57-1.21) 
0.96 (0.64-1.44) 
  
1 
0.88 (0.50-1.54) 
1.16 (0.66-2.05) 
 
1 
1.01 (0.56-1.82) 
1.54 (0.74-3.22) 
  
1 
0.48 (0.13-1.73) 
2.17 (0.51-9.23) 
 
1 
1.14 (0.71-1.83) 
1.01 (0.56-1.85) 
 
1 
1.14 (0.65-2.01) 
1.30 (0.75-2.25) 
Alcohol status 
  Never drinkers 
  Ex-drinkers 
  Current drinkers 
  
1 
0.97 (0.63-1.48) 
0.87 (0.61-1.25) 
 
1 
1.93 (0.51-7.37) 
1.37 (0.40-4.63) 
 
1 
0.92 (0.55-1.52) 
0.92 (0.62-1.38) 
  
1 
0.82 (0.36-1.84) 
0.97 (0.51-1.84) 
 
1 
0.99 (0.41-2.38) 
0.61 (0.28-1.30) 
  
1 
(N/A) 
0.63 (0.21-1.89) 
 
1 
1.84 (0.89-3.79) 
1.04 (0.55-1.98) 
 
1 
0.87 (0.44-1.74) 
0.81 (0.46-1.42) 
Fruits and 
vegetables  
  1
st 
third 
  2
nd 
third
 
  3
rd 
third
 
  
 
1 
1.18 (0.91-1.52) 
0.98 (0.75-1.28) 
 
 
1 
1.52 (0.73-3.19) 
1.83 (0.86-3.91) 
 
 
1 
1.89 (0.80-1.48) 
0.93 (0.68-1.28) 
  
 
1 
1.04 (0.66-1.62) 
0.82 (0.50-1.34) 
 
 
1 
0.84 (0.46-1.54) 
0.96 (0.55-1.65) 
  
 
1 
1.55 (0.53-4.54) 
2.30 (0.78-6.74) 
 
 
1 
1.04 (0.66-1.64) 
1.01 (0.63-1.62) 
 
 
1 
1.25 (0.83-1.89) 
0.88 (0.56-1.39) 
Red/processed 
meat  
  1
st 
third 
  2
nd 
third
 
  3
rd 
third 
  
 
1 
0.97 (0.75-1.26) 
1.00 (0.75-1.35) 
 
 
1 
0.86 (0.41-1.77) 
0.85 (0.37-1.96) 
 
 
1 
1.00 (0.73-1.37) 
1.11 (0.78-1.60) 
  
 
1 
1.21 (0.77-1.91) 
0.94 (0.56-1.58) 
 
 
1 
0.97 (0.51-1.83) 
1.27 (0.69-2.35) 
  
 
1 
0.67 (0.20-2.22) 
2.03 (0.66-6.24) 
 
 
1 
0.99 (0.63-1.54) 
0.85 (0.52-1.39) 
 
 
1 
0.94 (0.62-1.41) 
1.00 (0.61-1.63) 
Sodium intake  
  1
st 
third 
  2
nd 
third
 
  3
rd 
third
 
  
1 
0.90 (0.69-1.16) 
0.93 (0.71-1.22) 
 
1 
0.78 (0.38-1.63) 
0.62 (0.28-1.34) 
 
1 
0.88 (0.64-1.22) 
1.04 (0.75-1.46) 
  
1 
1.22 (0.76-1.97) 
1.50 (0.91-2.46) 
 
1 
0.66 (0.37-1.18) 
0.84 (0.46-1.52) 
  
1 
0.47 (0.13-1.78) 
0.91 (0.53-3.32) 
 
1 
1.23 (0.79-1.92) 
1.07 (0.65-1.76) 
 
1 
0.79 (0.52-1.19) 
0.71 (0.45-1.11) 
Dietary patterns 
  Pattern I 
  Pattern II
 
  Pattern III 
  
1 
0.94 (0.75-1.19) 
0.79 (0.55-1.15) 
 
1 
0.77 (0.38-1.53) 
0.78 (0.30-2.02) 
 
1 
0.97 (0.73-1.28) 
0.85 (0.56-1.31) 
  
1 
1.25 (0.83-1.89) 
0.90 (0.45-1.79) 
 
1 
0.72 (0.42-1.24) 
0.46 (0.21-1.05) 
  
1 
0.97 (0.39-2.38) 
0.51 (0.06-4.47) 
 
1 
0.80 (0.54-1.17) 
0.45 (0.22-0.93) 
 
1 
0.95 (0.63-1.43) 
1.10 (0.64-1.90) 
Abbreviations: HR – Hazard Ratios; CI – Confidence Intervals; N/A – not applicable (there is no ex-drinkers patients with an extent of disease as localised and/or local spread). 
a 
Adjusted to age, sex, education (continuous), extent of disease (grouped in localised and local spread; regional spread; advanced; unknown) ;
b
 Adjusted to age, sex, education (continuous), extent 
of disease (grouped in localised, local spread and regional spread; advanced; unknown); 
c 
adjusted to age, sex, education (continuous). 
.
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Figure 1. Survival probability according to age of gastric cancer patients using Kaplan-
Meier method 
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Figure 2. Survival probability according to extent of disease of gastric cancer patients 
using Kaplan-Meier method 
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5. General discussion and conclusions 
 
The present dissertation contributes to the understanding of the relationship 
between pre-diagnosis lifestyles and the survival of gastric cancer patients, taking into 
account the systematic review of the published articles addressing this topic and a 
large study with a long follow-up conducted in a high-risk Portuguese population. 
The meta-analysis is based in the most comprehensive systematic review on 
this topic, and provides a summary of the best available evidence on the relation 
between pre-diagnosis lifestyles and gastric cancer survival.  
The results from the cohort study are similar with the conclusions from the 
systematic review and meta-analysis. Most of the previous research [79-80] has 
addressed the relationship between foods or nutrients separately without taking into 
account the effect of dietary patterns. Our study adds the analysis also by dietary 
patterns. The present study also adds to previous investigations [79-85] the analysis of 
the pre-diagnosis determinants in relation with the extent of disease, which is an 
important factor for survival.  
Our findings suggest that only dietary pattern III, related with high consumptions 
of most food groups and low vegetable soup intake, was significantly associated with a 
better relative survival, but only for patients identified with an extent of disease as 
regional spread. The dietary patterns are population-dependent and therefore these 
results may not be generalizable to other settings, particularly to populations with 
different dietary habits.  
In conclusion, this dissertation showed no consistent effects of pre-diagnosis 
behaviours in the survival of gastric cancer patients, even among the subjects with 
clinical characteristics at diagnosis that are associated with a better prognosis. 
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7. Summary 
 
Pre-diagnosis lifestyle exposures and the survival of gastric cancer patients 
 
Gastric cancer is the fourth most common malignancy in the world and although 
is frequency has been declining for decades it remains the second leading cause of 
cancer mortality and ranks second among the cancers accounting for the highest 
number of disability-adjusted life years (DALYs). In Europe, the average 5-year relative 
survival rate of patients diagnosed between 2000 and 2002 was estimated in 24.9%, 
varying widely across countries.  
The geographical and temporal differences in gastric cancer survival may be 
explained by a heterogeneous distribution of the access to early diagnosis, and 
treatment across populations as well as differences in the socioeconomic status of the 
patients. The latter may also be associated with environmental exposures with potential 
impact both in the risk of gastric cancer and the patients‟ prognosis. 
The understanding of the relation between pre-diagnosis lifestyles and survival 
may contribute to a more accurate characterization of the burden associated with these 
exposures.  
The aim of the present dissertation was to study the relationship between pre-
diagnosis behaviours and the survival of gastric cancer patients. It includes two 
studies, with the following specific objectives: 
 To review systematically the published studies assessing the 
association between pre-diagnosis lifestyle exposures and the survival 
of gastric cancer patients (Manuscript I). 
 To quantify the association between pre-diagnosis lifestyle exposures 
and survival of gastric cancer patients in a Portuguese setting 
(Manuscript II). 
 
Manuscript I – Pre-diagnosis lifestyle exposures and survival of gastric cancer 
patients: systematic review and meta-analysis 
 
Published studies quantifying the association between pre-diagnosis smoking 
and alcohol intake and the survival of gastric cancer patients were identified through 
systematic review and meta-analysis in Pubmed® and EMBASE® up to April 2011. 
Summary Hazard ratio (HR) estimates and respective 95% confidence intervals 
(95%CI) were computed through by random-effects meta-analysis (DerSimonian and 
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Laird) with current vs. never for smoking and drinkers vs. non-drinkers for alcohol 
consumption. Heterogeneity was quantified using the I2 statistic.  
Seven articles, providing data from 6856 cases evaluated in seven countries 
(Canada, Japan, Italy, USA, Korea, Iran and Sweden), were eligible for meta-analysis. 
The summary HR was 1.08 (95%CI: 0.90-1.30) for smoking (current vs. never 
smokers; 9 estimates from 7 studies; I2=56.2%) and 1.13 (95%CI: 1.00-1.28) for 
alcohol consumption (drinkers vs. non-drinkers; 6 estimates from 5 studies; I2=13.2%). 
Only two studies assessed the effect of other dietary factors. 
 
Manuscript II – Pre-diagnosis lifestyle exposures and survival of gastric cancer 
patients: a cohort study from Portugal 
 
Incident cases of gastric cancer admitted to the surgery wards in two hospitals, 
between June 2001 and December 2006. Patients were interviewed regarding 
demographic, social, behavioural, and medical characteristics. For the year preceding 
the diagnosis, smoking habits was assessed and a validated food frequency 
questionnaire (FFQ) was used to estimate usual food intake.  
Survival curves were estimated by the Kaplan-Meier method and Cox 
proportional hazards regression models were used to estimate age-, sex-, education, 
extent of disease-adjusted hazard ratios (HRs) and 95% confidence intervals (95%CI). 
Maximum follow-up: 10 years. 
Three dietary patterns were identified: (I) high consumption of fruits and dairy 
products, and low consumption of alcoholic beverages; (II) low consumption of fruit, 
salads, vegetables, dairy products, fish and meat; (III) high consumptions of most food 
groups and low vegetable soup intake.  
Only dietary pattern III was correlated significantly with a better 5-year survival 
and just for an extent of disease as regional spread (HR, 0.45, 95%CI, 0.22-0.93). The 
results were not significant for other variables (alcohol, smoking, consumption of fruits 
and vegetables, ingestion of red and processed meat and ingestion of food with the 
highest contribution of sodium intake).  
 
Conclusions 
 
 According to a systematic review and meta-analysis from the literature, 
a lower survival of gastric cancer patients was related with alcohol 
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consumption, for smoking there is no association and there is almost no 
information on the effects of dietary factors. 
 The results from a cohort study conducted in Portugal confirm that pre-
diagnosis lifestyles have a small impact in the survival of gastric cancer 
patients.  
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8. Sumário 
 
Estilos de vida antes do diagnóstico e sobrevivência dos doentes com cancro 
gástrico 
 
O cancro gástrico é a quarta neoplasia maligna mais frequente e embora a sua 
incidência tenha vindo a diminuir ao longo de décadas, continua a ser a segunda 
principal causa de mortalidade por cancro e ocupa a segunda posição entre os 
cancros que contabilizam o maior número de anos de vida potencialmente perdidos 
(AVPP). Na Europa, a sobrevivência relativa média nos doentes diagnosticados entre 
2000 e 2002 foi estimada em 24,9%, variando largamente entre os países. 
As diferenças geográficas e temporais na sobrevivência de doentes com 
cancro gástrico pode ser explicada por uma distribuição heterogénea do acesso ao 
diagnóstico precoce e tratamento entre as populações, bem como diferenças no 
estatuto socioeconómico dos doentes. Também pode ser associada com as 
exposições ambientais com impacto potencial tanto no risco de cancro gástrico como 
no prognóstico dos doentes. 
A compreensão da relação entre os estilos de vida antes do diagnóstico e 
sobrevivência podem contribuir para uma caracterização mais precisa da carga 
associada a estas exposições. 
O objectivo desta dissertação foi estudar a relação entre estilos de vida antes 
do diagnóstico e a sobrevivência dos doentes com cancro gástrico, através 
consecução dos seguintes objectivos específicos: 
 Revisão sistemática dos estudos publicados que avaliam a associação 
entre a exposição pré-diagnóstica e a sobrevivência de doentes com 
cancro gástrico (Manuscrito I). 
 Quantificar a associação entre estilos de vida antes do diagnóstico e a 
sobrevivência dos doentes com cancro gástrico numa população 
portuguesa (Manuscrito II). 
 
Manuscrito I – Estilos de vida antes do diagnóstico e sobrevivência dos doentes 
com cancro gástrico: revisão sistemática e meta-análise 
 
Os estudos publicados que quantificavam a associação entre a história pré 
diagnostica do consumo de tabaco e de bebidas alcoólicas e a sobrevivência de 
doentes com cancro gástrico foram sistematicamente revistos na Pubmed® e 
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EMBASE® até Abril de 2011. Foi usado um modelo de efeitos aleatórios (DerSimonian 
e Laird) para calcular estimativas conjuntas de Hazard Ratio (HR) e respectivos 
intervalos de confiança de 95% (IC 95%) referentes à comparação dos níveis de 
exposição mais elevados com os mais baixos (fumadores versus não fumadores para 
o tabaco e para o consumo de álcool, consumidores de álcool versus não 
consumidores de álcool). A heterogeneidade foi quantificada através da estatística I2. 
Sete artigos foram elegíveis para meta-análise, fornecendo dados a partir de 6856 
casos avaliados em sete países (Canadá, Japão, Itália, EUA, Coreia, Irão e Suécia). 
O HR foi 1,08 (IC 95%: 0,90-1,30) para fumadores (fumadores versus não 
fumadores; 9 estimativas de 7 estudos; I2 = 56,2%) e 1,13 (IC 95%: 1,00-1,28) para o 
consumo de álcool (consumidores de álcool versus não consumidores de álcool, 6 
estimativas de cinco estudos, I2 = 13,2%). Apenas dois estudos avaliaram o efeito de 
outros factores dietéticos. 
 
Manuscripto II – Estilos de vida antes do diagnóstico e a sobrevivência dos 
doentes com cancro gástrico: um estudo de coorte de Portugal 
 
Foram avaliados casos incidentes de cancro gástrico internados nos serviços 
de cirurgia de dois hospitais, entre Junho de 2001 e Dezembro de 2006. Os doentes 
foram entrevistados sobre as suas características demográficas, sociais, 
comportamentais e médicas. O consumo de tabaco foi avaliado, assim como ingestão 
habitual de alimentos por um questionário de frequência alimentar (QFA) validado, 
com base em informação relativa ao ano anterior ao diagnóstico. 
As curvas de sobrevivência foram estimadas pelo método de Kaplan-Meier. 
Foram utilizados modelos de regressão de Cox para calcular Hazard Ratio ajustados 
para a idade, sexo, educação, extensão da doença, com os respectivos intervalos de 
confiança de 95% (IC 95%). O tempo máximo de seguimento foi de 10 anos. 
Três padrões alimentares foram identificados: (I) alto consumo de frutas e 
produtos lácteos, e baixo consumo de bebidas alcoólicas; (II) baixo consumo de frutas, 
saladas, legumes, lacticínios, peixe e carne; (III) consumos elevados da maioria dos 
grupos alimentares e baixa ingestão de sopa. 
Somente o padrão alimentar III foi correlacionado significativamente com uma 
melhor sobrevivência relativa a 5 anos, mas apenas para uma extensão da doença 
caracterizada por disseminação regional (HR, 0,45, 95% IC, 0,22-0,93). Os resultados 
não foram significativos para as outras variáveis (álcool, tabaco, consumo de frutas e 
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verduras, ingestão de carnes vermelhas e processadas e ingestão de alimentos com a 
elevada contribuição de sódio). 
 
Conclusões 
 
 De acordo com a revisão sistemática e meta-análise, o consumo de 
álcool está associado a uma menor sobrevivência dos doentes com 
cancro gástrico, não se observou uma relação significativa com o 
tabaco e a informação sobre os efeitos das exposições alimentares é 
escassa. 
 Os resultados de um estudo de coorte realizado em Portugal 
confirmam que os estilos de vida pré-diagnósticos têm um pequeno 
impacto na sobrevivência dos doentes com cancro gástrico.  
 
